Info: Read More
  • 中药标准品生产商,产品定制服务
  • 野漆树苷

    Rhoifolin

    野漆树苷
    产品编号 CFN99814
    CAS编号 17306-46-6
    分子式 = 分子量 C27H30O14 = 578.5
    产品纯度 >=98%
    物理属性 Yellow powder
    化合物类型 Flavonoids
    植物来源 The leaves of Turpinia arguya Seem.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    野漆树苷 CFN99814 17306-46-6 10mg QQ客服:1457312923
    野漆树苷 CFN99814 17306-46-6 20mg QQ客服:1457312923
    野漆树苷 CFN99814 17306-46-6 50mg QQ客服:1457312923
    野漆树苷 CFN99814 17306-46-6 100mg QQ客服:1457312923
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • University of Bordeaux (France)
  • Monash University (Australia)
  • Northeast Normal University Changchun (China)
  • Korea Food Research Institute(KFRI) (Korea)
  • University of Liège (Belgium)
  • University of the Basque Country (Spain)
  • University of Medicine and Pharmacy (Romania)
  • University of South Australia (Australia)
  • Research Unit Molecular Epigenetics (MEG) (Germany)
  • Julius Kühn-Institut (Germany)
  • Universitas Airlangga (Indonesia)
  • Weizmann Institute of Science (Israel)
  • Martin Luther University of Halle-Wittenberg (Germany)
  • Monash University Sunway Campus (Malaysia)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Industrial Crops and Products2021, 163:113313.
  • J Biochem Mol Toxicol.2017, 31(9)
  • Chin. Med.J.Res. Prac.2017, 31(4)
  • Front Pharmacol.2023, 14:1095083.
  • J Appl Biol Chem.2022, 65(4):pp.463-469.
  • Molecules.2021, 26(12):3652.
  • Appl. Sci. 2021, 11(23),11099.
  • Food Chem.2023, 404(Pt A):134517.
  • Molecules.2016, 21(6)
  • Metabolites.2020, 10(11):440.
  • Russian J Bioorganic Chemistry 2021, 47:1411-1417.
  • Int J Mol Sci.2022, 23(15):8687.
  • Chem Biol Interact.2016, 258:59-68
  • Planta Med.2022, 88(9-10):794-804.
  • Nutrients.2019, 12(1)
  • Horticulturae2022, 8(10), 975.
  • J Hematol Oncol.2018, 11(1):112
  • Molecules.2022, 27(22):7887.
  • Int J Mol Sci.2018, 19(9):E2528
  • Front Chem.2023, 11:1245071.
  • In Vivo.2022, 36(3):1136-1143.
  • ACS Synth Biol.2022, doi: 10.1021.
  • VNU Journal of Science2023, 39(2):24-33.
  • ...
  • 生物活性
    Description: Rhoifolin possesses a variety of significant biological activities including antioxidant, anti-inflammatory, antimicrobial, hepatoprotective and anticancer effects, it may be beneficial for diabetic complications through its enhanced adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and GLUT4 translocation. Rhoifolin has a radioprotective effect against radiation-induced decrease of blood platelets and cardiac biochemical lesions in whole body irradiated mice.
    Targets: GLUT | TNF-α | PGE | SOD
    In vitro:
    Evid Based Complement Alternat Med. 2011;2011:624375.
    Insulin-Mimetic Action of Rhoifolin and Cosmosiin Isolated from Citrus grandis (L.) Osbeck Leaves: Enhanced Adiponectin Secretion and Insulin Receptor Phosphorylation in 3T3-L1 Cells.[Pubmed: 20008903]
    Citrus grandis (L.) Osbeck (red wendun) leaves have been used in traditional Chinese medicine to treat several illnesses including diabetes. However, there is no scientific evidence supporting these actions and its active compounds.
    METHODS AND RESULTS:
    Two flavone glycosides, rhoifolin and cosmosiin were isolated for the first time from red wendun leaves and, identified these leaves are rich source for rhoifolin (1.1%, w/w). In differentiated 3T3-L1 adipocytes, rhoifolin and cosmosiin showed dose-dependent response in concentration range of o.oo1-5 μM and 1-20 μM, respectively, in biological studies beneficial to diabetes. Particularly, rhoifolin and cosmosiin at 0.5 and 20 μM, respectively showed nearly similar response to that 10 nM of insulin, on adiponectin secretion level. Furthermore, 5 μM of rhoifolin and 20 μM of cosmosiin showed equal potential with 10 nM of insulin to increase the phosphorylation of insulin receptor-β, in addition to their positive effect on GLUT4 translocation.
    CONCLUSIONS:
    These findings indicate that rhoifolin and cosmosiin from red wendun leaves may be beneficial for diabetic complications through their enhanced adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and GLUT4 translocation.
    Zhongguo Zhong Yao Za Zhi. 2014 Aug;39(16):3094-101.
    [Chemical constituents from Callicarpa nudiflora and their cytotoxic activities].[Pubmed: 25509294]
    The chemical consitituents from cytotoxic fraction of the Callicarpa nudiflora extract were isolated and purified by a combination of HP-20 macroporous resin, silica gel and Sephadex LH-20 column chromatographies.
    METHODS AND RESULTS:
    The structures were elucidated on the basis of the spectroscopic data and comparison of their spectroscopic data with reported data. The cytotoxicity was evaluated by the MTT assay. The 50% and 70% EtOH elutions of EtOH-extract showed significant cytotoxic activities, leading to the isolation of twelve compounds, which were identified as luteoloside(1), lutedin-4'-O-β-D-glucoside(2), 6-hydroxyluteolin-7-O-β-glucoside(3), lutedin-7-O-neohesperidoside(4), rhoifolin (5), luteolin-7, 4'-di-O-glucoside (6), forsythoside B (7), acteoside (8), alyssonoside (9), catalpol(10), nudifloside(11), and leonuride(12). Compounds 3-6, 10 and 12 were isolated from this genus for the first time, and compound 9 was isolated from this plant for the first time. The cytotoxicity assay demonstrated that flavonoids 1-6, in various concentrations, showed monolithic proliferation inhibitory activities against Hela, A549 and MCF-7 cell lines. Compounds 3, 5 and iridoid glycoside 11 possessed higher cytotoxicacivities.
    CONCLUSIONS:
    In short, flavonoids are the main components of cytotoxic extract from C. nudiflora, while phenylethanoid glycosides are the predominant ingredient but inactive to cancer cell lines. In addition, the minor iridoid glycoside expressed weak cytotoxic activity.
    Pharmacology & Clinics of Chinese Materia Medica, 2012(6):18-20.
    Study on the protective effect of rhoifolin against hepatic injury induced by triptolide[Reference: WebLink]
    Study on the protective effect of rhoifolin against hepatic injury induced by triptolide.
    METHODS AND RESULTS:
    The protective effects of rhoifolin at the concentration of 75,150,300μg/ml,on the in vitro damage of human L02 liver cells injured by triptolide at the concentration of 40μg/ml were evaluated with cell survival rates,which were determined by MTT assay.Sixty mice were randomly divided into six groups as follows: The drug groups mice were treated with rhoifolin for six day at the dose of 140,70,35mg/kg,respectively.The normal control group and the model control group took equivalent amount of distilled water by the same route.And mice in the positive control group were treated with 70mg/kg diammonium glycyrrhizinate.After the last administration,all groups except the normal control were administered with triptolide at dose of 0.625mg/kg by gavage to induce acute hepatic injury.Thereafter,the contents of ALT,AST in serum,the activities of SOD,MDA,GSH-Px and GST in the liver were measured and the hepatic histological changes were observed by optical microscope. The cell survival rates of human L02 liver cells injured by triptolide and then treated with rhoifolin at the concentration of 75,150,300μg/ml were significantly increased.The contents of ALT,AST in serum were significantly decreased,the content of MDA in the liver was also significantly lowered,and the activities of SOD,MDA,GSH-Px and GST in liver were significantly improved after preventive treatment with rhoifolin at the dose of 140,70,35mg/kg.Rhoifolin can ameliorated the hepatic pathological changes.
    CONCLUSIONS:
    The protective effect of rhoifolin against hepatic injury induced by triptolide was significant in vitro and in vivo.
    In vivo:
    J. Appl. Pharmaceut. Sci., 2012, 2(8):74-9.
    Anti-inflammatory effect of Apigenin-7-neohesperidoside (Rhoifolin) in carrageenin-induced rat edema model[Reference: WebLink]
    Flavonoids are normal constituents of the human diet and are known for a variety of biological activities. They have been reported to bring benefits in lowering inflammation and oxidative stress.
    METHODS AND RESULTS:
    The present investigation was performed first, to evaluate the anti-inflammatory activity of Rhoifolin and second, to search for the possible contributing mechanisms for this hypothesized effect. Rhoifolin caused a time and reverse dose dependent reduction of carrageenin-induced rat paw oedema. Following 4 hr of treatment, Rhoifolin at doses 2.5, 25 & 250 mg/kg caused a significant inhibition of rat paw edema volume by 14, 25 & 45 % respectively in comparison to the control group (74%). In addition to significantly abrogating prostaglandin E2 level, increasing doses of Rhoifolin significantly diminished the TNF-a release in the inflammatory exudates. In the same animal model, Rhoifolin increased the total antioxidant capacity in a reverse dose order, with the highest capacity obtained with the lowest dose tested.
    CONCLUSIONS:
    This study demonstrates for the first time the effectiveness.
    J Cell Physiol . 2019 Aug;234(10):17600-17611.
    Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways[Pubmed: 30854667]
    Abstract Prosthesis loosening is a highly troublesome clinical problem following total joint arthroplasty. Wear-particle-induced osteoclastogenesis has been shown to be the primary cause of periprosthetic osteolysis that eventually leads to aseptic prosthesis loosening. Therefore, inhibiting osteoclastogenesis is a promising strategy to control periprosthetic osteolysis. The possible mechanism of action of rhoifolin on osteoclastogenesis and titanium particle-induced calvarial osteolysis was examined in this study. The in vitro study showed that rhoifolin could strongly suppress the receptor activators of nuclear factor-κB (NF-κB) ligand-stimulated osteoclastogenesis, hydroxyapatite resorption, F-actin formation, and the gene expression of osteoclast-related genes. Western blot analysis illustrated that rhoifolin could attenuate the NF-κB and mitogen-activated protein kinase pathways, and the expression of transcriptional factors nuclear factor of activated T cells 1 (NFATc1) and c-Fos. Further studies indicated that rhoifolin inhibited p65 translocation to the nucleus and the activity of NFATc1 and NF-κB rhoifolin could decrease the number of tartrate-resistant acid phosphate-positive osteoclasts and titanium particle-induced C57 mouse calvarial bone loss in vivo. In conclusion, our results suggest that rhoifolin can ameliorate the osteoclasts-stimulated osteolysis, and may be a potential agent for the treatment of prosthesis loosening. Keywords: RANKL; osteoclast; rhoifolin; titanium particle.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 1.7286 mL 8.643 mL 17.2861 mL 34.5722 mL 43.2152 mL
    5 mM 0.3457 mL 1.7286 mL 3.4572 mL 6.9144 mL 8.643 mL
    10 mM 0.1729 mL 0.8643 mL 1.7286 mL 3.4572 mL 4.3215 mL
    50 mM 0.0346 mL 0.1729 mL 0.3457 mL 0.6914 mL 0.8643 mL
    100 mM 0.0173 mL 0.0864 mL 0.1729 mL 0.3457 mL 0.4322 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    野黄芩苷甲酯; Scutellarin methylester CFN90695 119262-68-9 C22H20O12 = 476.39 20mg QQ客服:2159513211
    高车前苷; Homoplantaginin CFN90344 17680-84-1 C22H22O11 = 462.40 20mg QQ客服:2159513211
    高车前素 7-O-新橙皮糖苷; Hispidulin 7-O-neohesperidoside CFN90892 156186-00-4 C28H32O15 = 608.6 5mg QQ客服:2056216494
    Comanthosid B; Comanthosid B CFN91174 70938-60-2 C23H22O12 = 490.4 5mg QQ客服:1457312923
    Comanthosid A; Comanthosid A CFN91173 70938-59-9 C24H24O12 = 504.5 5mg QQ客服:3257982914
    高车前素-4'-O-β-D-葡萄糖苷; Hispidulin 4'-O-beta-D-glucopyranoside CFN91833 244285-12-9 C22H22O11 = 462.4 5mg QQ客服:2056216494
    滨蓟黄甙; Cirsimarin CFN96507 13020-19-4 C23H24O11 = 476.43 5mg QQ客服:2056216494
    5,8,4'-三羟基-7-甲氧基黄酮8-O-葡萄糖甙; 5,8,4'-Trihydroxy-7-methoxyflavone 8-O-glucoside CFN97699 710952-13-9 C22H22O11 = 462.41 5mg QQ客服:215959384
    田蓟苷; Tilianin CFN92764 4291-60-5 C22H22O10 = 446.1 20mg QQ客服:1413575084
    蒙花苷; Linarin CFN98738 480-36-4 C28H32O14 = 592.6 20mg QQ客服:1457312923

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产